🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is not being conducted in the United States. Vildagliptin is an ...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2006-04
Trial ID
NCT00325117
Treatments Being Tested
Investigating the efficacy of Vildagliptin in delaying the progression of P...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-01
Trial ID
NCT06951334
Treatments Being Tested
The study design of this trial is open-label, randomized, multi-center, par...
Status
Completed
Location
Handok Pharmaceuticals
Start Date
2009-08
Trial ID
NCT00975065
The overarching hypothesis of this study is that vildagliptin (vilda) as ad...
Status
Completed
Location
Al-Azhar university
Start Date
2023-06-01
Trial ID
NCT07077525
Treatments Being Tested
The purpose of this study is to compare the effect of 16 weeks treatment wi...
Status
Completed
Location
Busan Saint Mary's Medical Center
Start Date
2009-12
Trial ID
NCT01882907
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of vildagliptin ...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2006-10
Trial ID
NCT00396357
Treatments Being Tested
The purpose of this study was to assess the efficacy and safety of vildagli...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-12
Trial ID
NCT02002221
Treatments Being Tested
A randomized versus placebo trial designed to evaluate the clinical and hum...
Status
Completed
Location
Second university of Naples
Start Date
2011-05
Trial ID
NCT01472432
Treatments Being Tested
This study will evaluate the efficacy and safety of vildagliptin 50 mg bid ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-10
Trial ID
NCT01233622
Treatments Being Tested
This study investigated how vildagliptin (a di-peptidyl peptidase 4 inhibit...
Status
Completed
Location
Bezmialem VU
Start Date
2012-07
Trial ID
NCT01963130